Caricamento...
Nanotherapeutics in transplantation: How do we get to clinical implementation?
Patients undergoing organ transplantation transition from one life‐altering issue (organ dysfunction) to a lifelong commitment—immunosuppression. Regimens of immunosuppressive agents (ISAs) come with significant side effects and comorbidities. Recently, the use of nanoparticles (NPs) as a solution t...
| Autori principali: | , , , , , |
|---|---|
| Natura: | Online Articolo testo |
| Lingua: | English |
| Pubblicazione: |
John Wiley and Sons Inc.
2022
|
| Soggetti: | |
| Accesso online: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081154/ https://www.ncbi.nlm.nih.gov/pubmed/35224837 http://dx.doi.org/10.1111/ajt.17012 |